本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

47.27
+1.653.62%
盘后46.55-0.7200-1.52%19:53 EDT
成交量:282.05万
成交额:1.33亿
市值:89.76亿
市盈率:-13.37
高:48.07
开:45.63
低:45.56
收:45.62
数据加载中...
2025/02/28

重要事件披露

Form 8-K - Current report
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/20

重要事件披露

Form 8-K - Current report
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/25

重要事件披露

Form 8-K - Current report
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/06

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/11

重要事件披露

Form 8-K - Current report